Wow....Im surprised that Alere wants to jump into this market years behind Orasure and Chembio D. I guess for the grant money. Trying to creat untried assays. With already slumping earnings on increased revenues.
Big risk as I see it...but will be 2-4 years before they find out if the end products will even be viable (work), not to mention if there will be room in the crowded market for these two new products. We will see....time will tell...but Im not willing to bet my money on a speculation. Either Alere is desperate for product revenue or they desperate to become a speculative investment again.
Congratulations. You guys continue to vindicate the wisdom of my investment and I appreciate it greatly. My question is in regards to the bovine TB test. When research and things that I have read before, challenges with antigens and the antibodies to identify this. Is it safe to assume that by getting the approval for this bovine TB test that, perhaps, you're on the right track towards getting to a human test that would -- you'd be happy with the results and meet the requirements?
Lawrence A. Siebert - Executive Chairman, Chief Executive Officer, President, Chairman of Chembio Diagnostic Systems Inc, Chief Executive Officer of Chembio Diagnostics Inc and President of Chembio Diagnostic Systems Inc
Yes, I think that's dangerous to make that jump. The issue in the developing world or even in the United States for detecting active pulmonary TB, not to mention detecting some of the most -- the drug-resistant forms, which is, maybe, something you've read about -- certainly, we've read about. Certainly, some of the reagents that we use can be used in both applications, but we would need to get to a different level of -- and we'd make progress on this. I don't want to tell you that we haven't made progress, but we still have more work to do than where we are with the veterinary tests in order to have a product that would meet the needs of the market."
From the most recent Chembio CC.....The head guru says re: a human active TB test..we still have more work to do"